World's leading clinical conference on bone, joint and muscle health
Programme Sponsored sessions
Friday April 17th - CEST Timezone
08:00 - 09:00
Auditorium 1
Amgen Sponsored Breakfast Satellite Symposium: From Risk Stratification to Innovation: Advancing Care for Very High-risk Patients
Chairperson: Nicholas Harvey
Chairperson: Nicholas Harvey
08:00
Auditorium 1
Very High-risk Fracture: Why Stratification Must Drive Action
08:00
Auditorium 1
From First Fracture to Re-fracture: Why Systems Fail and the Importance of FLS
08:00
Auditorium 1
Discussion and Q&A
08:00 - 09:00
Auditorium 2
Gedeon Richter Sponsored Breakfast Satellite Symposium: Opportunities and controversies in osteoporosis management using sequential therapies
Chairpersons: Serge Ferrari, Enrique Casado
Chairpersons: Serge Ferrari, Enrique Casado
08:00
Auditorium 2
High versus very high risk across guidelines: when is an anabolic-first approach appropriate?
08:00
Auditorium 2
Fracture on therapy: when does it represent treatment failure, and what is the optimal therapeutic sequence?
12:15 - 13:45
Auditorium 1
UCB Sponsored Lunch Satellite Symposium: Protecting her future with romosozumab first
Chairperson: Prof. Kassim Javaid
Chairperson: Prof. Kassim Javaid
12:15
Auditorium 1
Welcome and Introduction
12:15
Auditorium 1
Case 1: The urgent imperative
12:15
Auditorium 1
Case 2: Breaking the cycle
12:15
Auditorium 1
Case 3: Rebuilding foundations in very high fracture risk
12:15
Auditorium 1
Key takeaways and conclusions
12:15
Auditorium 1
Faculty Q&A and symposium close
12:15 - 13:45
Auditorium 2
Viatris Sponsored Lunch Satellite Symposium: Transforming Osteoarthritis Care: From Early Intervention to Long-Term Outcomes
Chairperson: Jean-Yves Reginster
Chairperson: Jean-Yves Reginster
12:15
Auditorium 2
Welcome and Introduction
12:15
Auditorium 2
The OA Treatment Journey: From Early Intervention to Long-Term Mangement
12:15
Auditorium 2
Holistic OA Management: How Disease Severity Can Guide NSAID Choice
12:15
Auditorium 2
Live Q&A and Closing Remarks
12:15
Auditorium 2
Panel theme: Holistic OA Panorama
14:00 - 15:00
MR - D3
Alexion Sponsored Meet-the-Expert Session: Beyond vitamin D and calcium: Rethinking bone monitoring in hypoparathyroidism
Chairpersons/Speakers: Aliya Khan, Maria Luisa Brandi
Chairpersons/Speakers: Aliya Khan, Maria Luisa Brandi
14:00
MR - D3
HypoPT overview and unmet medical need
14:05
MR - D3
Recent RWE publications on HypoPT disease burden across various regions, including bone manifestations
14:15
MR - D3
Guidelines: focus on latest bone monitoring updates - 2025 best practice recommendations (Khan 2025) & 2025 ESE guidelines (Bollerslev 2025)
14:35
MR - D3
Clinical practice – proposed approach: Patient case
14:55
MR - D3
Q&A and close
17:00 - 18:30
Auditorium 1
Echolight Sponsored Satellite Symposium: REMS for Addressing Unmet Clinical Needs in Osteoporosis Care
Chairperson: Jean-Yves Reginster
Chairperson: Jean-Yves Reginster
17:00
Auditorium 1
REMS Technology in Clinical Practice: Applications That Enhance Osteoporosis Diagnosis
17:00
Auditorium 1
From Innovation to Clinic: REMS as a Breakthrough Tool in Osteoporosis Management
17:00
Auditorium 1
Identifying Fragility Before Fractures Occur: The Added Value of REMS in Osteoporosis Care
Saturday April 18th - CEST Timezone
08:00 - 09:00
Auditorium 1
Kyowa Kirin Sponsored Educational Lecture: Low phosphate and the bone doctor
Chairperson/Speaker: Prof. Maria Luisa Brandi
Chairperson/Speaker: Prof. Maria Luisa Brandi
08:00
Auditorium 1
Welcome, introduction and objectives
08:05
Auditorium 1
Improving diagnosis through routine phosphate testing and timely action
08:20
Auditorium 1
Phenotypic variability in hypophosphatemia
08:35
Auditorium 1
Spotlight on delayed diagnosis: Hereditary and acquired chronic hypophosphatemia in practice
08:45
Auditorium 1
Shared experiences of the bone doctor: Advancing clinical practice in the diagnosis and management of hypophosphatemic disorders
08:55
Auditorium 1
Summary and close
08:00 - 09:00
Auditorium 2
Sandoz Sponsored Breakfast Satellite Symposium: Biosimilars in bone health: translating clinical evidence into sustainable outcomes
Chairperson: Prof. Richard Eastell
Chairperson: Prof. Richard Eastell
08:00
Auditorium 2
Welcome and introduction
08:05
Auditorium 2
The premise and promise of biosimilars
08:15
Auditorium 2
Real-world insights: experience with initiation and transition to biosimilar denosumab in Canada
08:30
Auditorium 2
Denosumab in clinical practice: strategies for sustained patient outcomes
08:50
Auditorium 2
Q&A session
12:15 - 13:45
Auditorium 1
Theramex Sponsored Lunch Satellite Symposium: Rebuilding bone, advancing outcomes: Abaloparatide▼evidence across the patient spectrum
Chairperson: Jean-Yves Reginster
Chairperson: Jean-Yves Reginster
12:15
Auditorium 1
Is it time to rethink bone anabolism?
12:25
Auditorium 1
Why cortical bone matters: sharpening clinical decisions for imminent-risk patients
12:45
Auditorium 1
Optimising bone building after recent fracture: the Abaloparatide experience
13:05
Auditorium 1
The window of opportunity in high-risk postmenopausal women: early intervention with Abaloparatide
13:25
Auditorium 1
Summarising the Abaloparatide journey: Mechanism, timing and clinical confidence
13:30
Auditorium 1
Q&A from the Audience
12:15 - 13:45
Auditorium 2
Alexion Sponsored Lunch Satellite Symposium: Advances in the Diagnosis and Management of Patients With Hypophosphatasia (HPP) Across the Disease Continuum
Chairperson: Maria Luisa Brandi
Chairperson: Maria Luisa Brandi
12:15
Auditorium 2
Welcome and Introductions
12:20
Auditorium 2
HPP Presentation and Diagnosis Across the Disease Continuum
12:45
Auditorium 2
HPP Disease Impact and Management Throughout the Patient Lifespan
13:10
Auditorium 2
Future Directions in HPP
13:35
Auditorium 2
Q&A Session